Tobias Financial Advisors, Inc. Electro Core, Inc. Transaction History

Tobias Financial Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.21 - $0.36 $13,344 - $22,876	63,547 Added 71.04%	153,000 $39,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $0.68 $29,231 - $43,211	-63,547 Reduced 41.53%	89,453 $36,000
Q1 2022 May 09, 2022	BUY	$0.5 - $0.88 $76,500 - $134,640	153,000 New	153,000 $90,000
Q4 2021 Feb 09, 2022	SELL	$0.58 - $1.09 $58,579 - $110,090	-101,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$0.93 - $1.18 $26,013 - $33,005	27,971 Added 38.3%	101,000 $114,000

Q4 2020 Feb 12, 2021	BUY	$1.44 - $1.98 $4,285 - $5,892	2,976 Added 4.25%	73,029 $114,000
Q1 2020 May 13, 2020	BUY	$0.33 - $1.62 $14,553 - $71,442	44,100 Added 169.92%	70,053 $67,000
Q4 2019 Feb 04, 2020	BUY	$1.23 - $2.67 $31,922 - $69,294	25,953 New	25,953 $41,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $445M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Tobias Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tobias Financial Advisors, Inc. with notifications on news.